These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 447438)

  • 1. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):357-60. PubMed ID: 489203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Molina HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):271-5. PubMed ID: 7107075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Tabernero JM; Rubio F
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):416-20. PubMed ID: 500264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of ascites on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Macias JG; Diez JL; Nieto MJ
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):57-61. PubMed ID: 7372376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of experimentally induced renal impairment on the pharmacokinetics of cefadroxil in rabbits.
    Mariño EL; Dominguez-Gil AA; Cepeda M; Otero MJ; Dominguez-Gil A
    Arzneimittelforschung; 1981; 31(3):478-81. PubMed ID: 7194673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefoxitin in patients undergoing hemodialysis.
    Garcia MJ; Dominguez-Gil A; Tabernero JM; Bondia Román A
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):366-70. PubMed ID: 489205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of type of dialyzer on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):197-202. PubMed ID: 6862725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of amikacin in children with normal and impaired renal function.
    Lanao JM; Dominguez-Gil AA; Dominguez-Gil A; Málaga S; Crespo M; Santos F
    Kidney Int; 1981 Jul; 20(1):115-21. PubMed ID: 7300106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefoxitin in patients with normal or impaired renal function.
    Garcia MJ; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Eur J Clin Pharmacol; 1979 Sep; 16(2):119-24. PubMed ID: 499308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition kinetics of dibekacin in normal subjects and in patients with renal failure.
    Arancibia A; Chávez J; Ibarra R; Ruiz I; Icarte A; Thambo S; Chávez H
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):38-43. PubMed ID: 3557728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of naproxen in healthy volunteers and in patients with diabetic microangiopathy.
    Calvo MV; Dominguez-Gil A; Miralles JM; de Pablo F
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):486-91. PubMed ID: 528094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kinetics of multiple-dose amikacin in the newborn infant].
    Olivesi A; Camboulives J; Charrel C; Unal D
    Ann Anesthesiol Fr; 1981; 22(2):212-8. PubMed ID: 6115610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural fluid levels of cefoxitin in patients with renal impairment.
    Barrueco M; Otero MJ; Garcia MJ; Lanao JM; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):485-9. PubMed ID: 3781682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and clinical experience with amikacin. A new aminoglycoside antibiotic].
    Lode H; Grunert K; Koeppe P; Langmaack H
    Dtsch Med Wochenschr; 1976 Sep; 101(36):1312-7. PubMed ID: 782811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of cefoxitin in the elderly.
    Garcia MJ; Garcia A; Nieto MJ; Dominguez-Gil A; Alonso G; Mellado L
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):503-9. PubMed ID: 7203727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of intravenous mezlocillin in patients with normal and impaired renal function (author's transl)].
    Cano JP; Rigault JP; Gevaudan MJ; Saingra S; Murisasco A; Charpin J
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):335-9. PubMed ID: 6460972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of amikacin in dogs.
    Baggot JD; Ling GV; Chatfield RC
    Am J Vet Res; 1985 Aug; 46(8):1793-6. PubMed ID: 4037511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of amikacin in patients with impaired renal function.
    McHenry MC; Wagner JG; Hall PM; Vidt DG; Gavan TL
    J Infect Dis; 1976 Nov; 134 SUPPL():S343-8. PubMed ID: 993627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.